MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yool, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yool, A. J.

Block of the inactivating potassium channel by clofilium and hydroxylamine depends on the sequence of the pore region

AJ Yool

Department of Physiology, University of Arizona College of Medicine, Tucson 85724.

Cardiac antiarrhythmic compounds are a diverse group divided into classes that differ in their mechanisms of action. Recent attention has focused on class III compounds, which prolong the action potential by blocking K+ channels. The purpose of this study was to characterize the mechanisms of actions of a class III compound, clofilium, and a simple analog, hydroxylamine, on an inactivating K+ channel. The defined system used a cloned inactivating K+ channel (Shaker-B) expressed in Xenopus oocytes. This channel is similar in physiological properties and core sequence to the inactivating K+ channel cloned from mammalian heart. Results presented here demonstrate that clofilium (100 microM) and hydroxylamine (10 mM) can cause use-dependent block, depending on the sequence of the pore region. A mutation of the pore known to influence selectivity and tetraethylammonium binding (threonine-441 to serine) confers use-dependent sensitivity to hydroxylamine and clofilium. Hybrid channels were formed from the coinjection of wild- type and mutant channel mRNAs; the analysis of block with the hybrid channels suggests that binding of hydroxylamine involves all subunits of the tetrameric channel, whereas clofilium affects channels containing as few as one mutant subunit. The simplest interpretation is that all four subunits contribute to an internal binding site for blockers such as clofilium and hydroxylamine and threonine-441 influences this binding site. The effectiveness of clofilium, unlike hydroxylamine, on the hybrid channels may reflect its structural complexity, which could allow interaction with a broader receptor site. Future studies will test this idea using other class III-related compounds.

Volume 46, Issue 5, pp. 970-976, 11/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
G. Tang, L. Wu, and R. Wang
The Effect of Hydroxylamine on KATP Channels in Vascular Smooth Muscle and Underlying Mechanisms
Mol. Pharmacol., May 1, 2005; 67(5): 1723 - 1731.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
E. Schnepf, N. Crickmore, J. Van Rie, D. Lereclus, J. Baum, J. Feitelson, D. R. Zeigler, and D. H. Dean
Bacillus thuringiensis and Its Pesticidal Crystal Proteins
Microbiol. Mol. Biol. Rev., September 1, 1998; 62(3): 775 - 806.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. J. Snyders and S. W. Yeola
Determinants of Antiarrhythmic Drug Action : Electrostatic and Hydrophobic Components of Block of the Human Cardiac hKv1.5 Channel
Circ. Res., September 1, 1995; 77(3): 575 - 583.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics